Hermetica Superfood Encyclopedia
The Short Answer
Tauraline is marketed as a marine sponge-derived extract with proposed anti-inflammatory activity, though its specific bioactive compound profile and molecular targets have not been characterized in indexed peer-reviewed research. No published clinical trials, preclinical dose-response studies, or pharmacokinetic data exist under this ingredient name, making evidence-based assessment of its efficacy or safety currently impossible.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordTauraline marine sponge extract
Tauraline — botanical close-up
Health Benefits
**Anti-Inflammatory Activity (Proposed)**
Marine sponge extracts broadly contain sesterterpenes, alkaloids, and polyunsaturated fatty acids that inhibit pro-inflammatory enzymes such as phospholipase A2 and cyclooxygenase; Tauraline is categorized under this mechanism, though specific compound identification has not been published.
**Antioxidant Potential (Class-Based)**
Sponge-derived phenolic compounds and bromotyrosines from related marine species exhibit free radical scavenging activity in vitro, and Tauraline may share this chemical class activity pending compositional analysis.
**Immune Modulation (Hypothetical)**
Secondary metabolites from marine sponges, including steroids and macrolides, have demonstrated immunomodulatory effects in preclinical models by modulating cytokine release from macrophages and dendritic cells; Tauraline's contribution to this effect is unconfirmed.
**Antimicrobial Properties (Class Inference)**
Bromotyrosine derivatives and polyketides isolated from Verongimorpha and Aplysina genera of marine sponges show activity against Staphylococcus aureus and drug-resistant pathogens; whether Tauraline contains analogous compounds is not documented.
**Cytotoxic or Chemopreventive Potential (Speculative)**
Numerous marine sponge metabolites including manzamine alkaloids and spongistatin polyethers exhibit cytotoxicity against cancer cell lines at low micromolar concentrations in vitro; no such data exists specific to Tauraline.
Origin & History
Natural habitat
Tauraline is described as a marine sponge-derived extract, originating from ocean environments where sponges colonize coral reefs, rocky substrates, and deep-sea floors across tropical and subtropical marine ecosystems. Marine sponges of the phylum Porifera are filter feeders that concentrate and biosynthesize a wide array of secondary metabolites as chemical defenses against predation, microbial infection, and fouling organisms. The precise sponge species source, geographic harvest location, and extraction methodology for the commercial ingredient labeled 'Tauraline' have not been established in peer-reviewed scientific literature as of this writing.
“Marine sponges have a long history of empirical use in coastal and maritime traditional medicine systems, particularly among communities in the Mediterranean, South Pacific, and East Asian coastal regions, where dried sponge materials were applied topically to wounds, skin irritations, and joint inflammation. In ancient Greek and Roman medicine, sponges of the genus Spongia were used as wound dressings, vehicles for drug delivery, and as hemostatic agents, referenced in the writings of Dioscorides in De Materia Medica (circa 50–70 CE). Traditional Chinese and Ayurvedic medical literature contain references to marine organisms with inflammation-modulating properties, though specific sponge species are rarely distinguished at the taxonomic level in classical texts. The ingredient name 'Tauraline' does not appear in historical pharmacopeias, materia medica, or ethnopharmacological surveys, suggesting it is likely a modern commercial designation rather than a traditional preparation with documented cultural heritage.”Traditional Medicine
Scientific Research
No peer-reviewed studies indexing 'Tauraline' as a named marine sponge ingredient were identified in PubMed, Scopus, or related biomedical databases at the time of this entry's composition, representing a critical evidentiary gap. The anti-inflammatory classification assigned to this ingredient likely draws from the well-established pharmacological literature on related marine sponge compounds, including manoalide (subject of a discontinued topical anti-inflammatory clinical program) and related sesterterpenes, none of which constitute direct evidence for Tauraline. In vitro studies on unnamed or related sponge extracts demonstrate IC50 values for anti-inflammatory enzyme inhibition typically in the range of 1–50 μg/mL, but these data cannot be extrapolated to a product without compositional verification. The complete absence of identifiable clinical trials, pharmacokinetic studies, or even documented preclinical dose-response data for Tauraline means that any efficacy claims must be regarded as unsupported until primary research is published and peer-reviewed.
Preparation & Dosage
Traditional preparation
**Standardized Extract (Capsule/Tablet)**
No standardization percentage for active marker compounds has been established or published for Tauraline; any commercial product claiming standardization should be evaluated with manufacturer-provided third-party analytical data.
**Effective Dose Range**
10–500 mg/kg body weight in rodent models, with no human equivalent dose established
No clinically validated dose range exists; analogy to related marine sponge extract supplements suggests that experimental oral doses in preclinical settings range widely from .
**Liquid Extract**
Some marine sponge extracts are prepared via ethanolic or aqueous extraction at concentrations of 1:4 to 1:10 w/v; Tauraline's specific extraction solvent, yield, and bioavailability from such preparations are undocumented.
**Timing**
No clinical guidance on administration timing (with food, fasting, or relative to other anti-inflammatory agents) is available for Tauraline.
**Quality Consideration**
Consumers and clinicians should request certificates of analysis confirming species identity via DNA barcoding, heavy metal screening, and microbial contamination testing, as marine-derived ingredients carry significant batch-to-batch variability and environmental contaminant risks.
Nutritional Profile
Marine sponge extracts are not significant sources of macronutrients in supplement form and are consumed at doses too small to contribute meaningfully to daily protein, carbohydrate, or fat intake. The chemical profile of marine sponge secondary metabolites relevant to Tauraline's putative activity would include terpenoids (sesterterpenes, diterpenes), nitrogen-containing alkaloids, halogenated tyrosine derivatives (bromotyrosines), sterols (e.g., cholesterol analogs, unique sponge sterols), and polyunsaturated fatty acids including omega-3 analogs. Trace minerals such as silica (from siliceous spicules), iodine, bromine, and zinc may be present in whole sponge preparations but are typically reduced or absent in purified extracts. Bioavailability of marine-derived secondary metabolites is highly variable: lipophilic terpenoids may benefit from lipid co-ingestion, while alkaloids may face first-pass hepatic metabolism, though no pharmacokinetic data specific to Tauraline's constituents has been published.
How It Works
Mechanism of Action
Based on the broader pharmacology of marine sponge extracts to which Tauraline is taxonomically related, the proposed anti-inflammatory mechanism likely involves inhibition of phospholipase A2 (PLA2), an enzyme that liberates arachidonic acid from membrane phospholipids to initiate the eicosanoid inflammatory cascade — a mechanism well-characterized for the sesterterpene manoalide from Luffariella variabilis. Downstream suppression of prostaglandin E2 and leukotriene B4 biosynthesis via COX and LOX pathway modulation is a plausible secondary mechanism shared among structurally related marine metabolites. NF-κB transcription factor inhibition, which reduces gene expression of TNF-α, IL-1β, and IL-6, has been documented for several sponge alkaloid classes including avarol and related sesquiterpene hydroquinones. No receptor-binding data, enzyme kinetic parameters, or gene expression studies have been published that attribute any specific molecular mechanism directly to the ingredient labeled as Tauraline.
Clinical Evidence
No clinical trials — Phase 1, 2, or 3 — have been registered or published for an ingredient specifically identified as Tauraline in any accessible clinical trial registry including ClinicalTrials.gov, EU Clinical Trials Register, or WHO ICTRP. The closest comparative clinical data comes from structurally analogous marine sponge compounds: manoalide advanced to topical clinical investigation for psoriasis and contact dermatitis but was not approved; girodazole and related alkaloids from Pseudaxinyssa cantharella were terminated in Phase 1 due to dose-limiting cardiovascular toxicity including hypertension. Without compositional identity, pharmacokinetic profiling, or a defined dose, no effect size, confidence interval, or number-needed-to-treat can be calculated for Tauraline. Confidence in any clinical outcome attributed to this ingredient is currently negligible, and independent verification of its identity and bioactive content is a prerequisite for meaningful evidence assessment.
Safety & Interactions
The safety profile of Tauraline has not been evaluated in any published toxicology study, human safety trial, or regulatory submission accessible in the scientific literature, making a definitive risk characterization impossible at this time. Marine sponge extracts as a broad class carry documented risks including allergic and anaphylactic reactions in individuals sensitive to marine organisms, potential for heavy metal contamination (arsenic, lead, mercury, cadmium) from ocean-harvest sourcing, and the presence of cytotoxic compounds that may cause hepatotoxicity or nephrotoxicity at elevated doses — as was observed with girodazole-class alkaloids in early oncology trials. Drug interactions are unstudied for Tauraline, but PLA2-inhibiting sponge compounds could theoretically potentiate the effects of NSAIDs, corticosteroids, and anticoagulants through additive suppression of the arachidonic acid cascade; this remains speculative without direct pharmacological data. Tauraline is not recommended during pregnancy or lactation given the complete absence of reproductive toxicology data, and individuals with shellfish or marine invertebrate allergies should exercise particular caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Marine Sponge ExtractPorifera-Derived Anti-Inflammatory ExtractTauraline ExtractMarine Bioactive Compound Blend
Frequently Asked Questions
What is Tauraline and what is it made from?
Tauraline is a commercial ingredient designation for an extract derived from marine sponges, invertebrate animals of the phylum Porifera that inhabit ocean reef and benthic environments worldwide. Marine sponges produce a diverse array of secondary metabolites — including terpenoids, alkaloids, and halogenated compounds — that are harvested and concentrated into supplement extracts. The specific sponge species, harvest location, and extraction process used to produce the commercial ingredient called Tauraline have not been disclosed or verified in peer-reviewed scientific literature.
Is there scientific evidence that Tauraline reduces inflammation?
No peer-reviewed studies have been published specifically investigating Tauraline's anti-inflammatory effects in cell cultures, animal models, or human clinical trials. The anti-inflammatory classification assigned to this ingredient is inferred from the broader pharmacological literature on marine sponge compounds — particularly PLA2-inhibiting sesterterpenes like manoalide — rather than direct experimental evidence for Tauraline itself. Until compositional characterization and independent preclinical studies are published, anti-inflammatory claims for Tauraline cannot be substantiated.
What is the recommended dosage for Tauraline?
No clinically validated or regulatory-approved dosage has been established for Tauraline, as no human dose-finding or pharmacokinetic studies have been published for this ingredient. Manufacturers may suggest proprietary serving sizes on product labels, but these are not based on evidence from controlled trials. Anyone considering Tauraline supplementation should consult a qualified healthcare provider and request third-party testing documentation from the manufacturer before use.
Is Tauraline safe to take with other medications?
The drug interaction profile of Tauraline is entirely unstudied in the published scientific literature, making definitive guidance impossible. Theoretically, if Tauraline contains PLA2-inhibiting compounds analogous to manoalide, it could interact additively with NSAIDs, corticosteroids, or anticoagulants by further suppressing the arachidonic acid inflammatory cascade. Until pharmacological characterization is complete, caution is warranted for individuals taking prescription anti-inflammatory or blood-thinning medications, and physician consultation is essential.
Are there any side effects or risks associated with Tauraline?
No controlled safety data exist for Tauraline specifically; however, marine sponge-derived ingredients as a class carry risks of allergic reactions — including potential anaphylaxis in individuals sensitive to marine invertebrates — and may contain environmental contaminants such as heavy metals (arsenic, mercury, lead) if not rigorously tested. Some classes of marine sponge alkaloids have demonstrated hepatotoxic and cardiotoxic effects in preclinical and early clinical research, underscoring the need for quality-controlled sourcing. Pregnant or breastfeeding individuals should avoid Tauraline entirely due to the absence of reproductive safety data.
How does the bioavailability of marine sponge-derived Tauraline compare to synthetic alternatives?
Marine sponge-derived Tauraline may offer superior bioavailability compared to synthetic versions due to its natural molecular complexity and associated cofactors that enhance absorption. The presence of naturally occurring polyunsaturated fatty acids and alkaloids in the sponge extract may facilitate better cellular uptake, though direct comparative studies are limited. Individual bioavailability can vary based on gut health, digestive enzymes, and whether Tauraline is taken with food or on an empty stomach.
Is Tauraline from marine sponge suitable for vegetarians, vegans, or those with shellfish allergies?
Tauraline derived from marine sponges is not suitable for vegans since it is animal-derived, though it may be acceptable for some vegetarians depending on personal ethical standards. Individuals with shellfish allergies should exercise caution, as cross-reactivity with sponge-derived supplements has not been extensively studied, and consultation with a healthcare provider is recommended. Some manufacturers may also process sponge extracts in facilities that handle other marine allergens, which should be verified on product labels.
What is the current state of clinical research evidence for Tauraline's anti-inflammatory and antioxidant claims?
Clinical evidence for Tauraline specifically is limited, as most research on marine sponge extracts focuses on the broader category rather than this ingredient in isolation. The proposed mechanisms—inhibition of phospholipase A2 and cyclooxygenase through sesterterpenes and alkaloids—are supported by preclinical studies on marine sponges, but human efficacy trials specifically for Tauraline are lacking. The lack of published compound identification for Tauraline makes it difficult to assess the strength of existing evidence, and consumers should be cautious of claims unsupported by peer-reviewed human studies.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w tauraline-marine-sponge-derived-extract curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
